Cargando…

Garnet-Based All-Ceramic Lithium Battery Enabled by Li(2.985)B(0.005)OCl Solder

Garnet-based bulk-type all-ceramic lithium battery (ACLB) is considered to be highly safe, but its electrochemical performance is severely hindered by the huge cathode/electrolyte interfacial resistance. Here, we demonstrate an in situ coated Li(2.985)B(0.005)OCl as sintering solder, which is unifor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Wuliang, Lai, Zhengzhe, Dong, Xiaoli, Li, Panlong, Wang, Yonggang, Xia, Yongyao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195548/ https://www.ncbi.nlm.nih.gov/pubmed/32361271 http://dx.doi.org/10.1016/j.isci.2020.101071

Ejemplares similares

Stabilization of garnet/Li interphase by diluting the electronic conductor
por: Feng, Wuliang, et al.
Publicado: (2022)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
por: Inoue, Kenji, et al.
Publicado: (2012)

Retract p < 0.005 and propose using JASP, instead
por: Perezgonzalez, Jose D., et al.
Publicado: (2018)

The assessment of intrinsic credibility and a new argument for p < 0.005
por: Held, Leonhard
Publicado: (2019)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Nakakura, Shunsuke, et al.
Publicado: (2012)

Structure and piezo-ferroelectricity relationship study of (K(0.5)Na(0.5))(0.985)La(0.005)NbO(3) epitaxial films deposited on SrTiO(3) by sputtering
por: H´Mŏk, H´Linh, et al.
Publicado: (2017)

Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy
por: Lázaro-Carrasco de la Fuente, Jesús, et al.
Publicado: (2022)

Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
por: Molinelli, Elisa, et al.
Publicado: (2020)

Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: A patient-use study
por: Paolera, Mauricio D, et al.
Publicado: (2008)

Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
por: Radcliffe, Nathan, et al.
Publicado: (2020)

The temperature stability of 0.005°C for the concrete floor in the CERN Transfer Tunnel #1 hosting the Precision Laser Inclinometer
por: Azaryan, N, et al.
Publicado: (2017)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
por: Mizoguchi, Takanori, et al.
Publicado: (2012)

Noninferiority Study Comparing Latanoprost 0.005% Without Versus With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension
por: Wirta, David, et al.
Publicado: (2022)

Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series
por: Del Rosso, James Q., et al.
Publicado: (2022)

Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
por: Miyashiro, Michael J, et al.
Publicado: (2010)

Sodium Hypochlorite 0.005% Versus Placebo in the Treatment of Mild to Moderate Acne: A Double-Blind Randomized Controlled Trial
por: Dorostkar, Azadeh, et al.
Publicado: (2021)

Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
por: Özkurt, Yelda Buyru, et al.
Publicado: (2009)

A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
por: Weinreb, Robert N, et al.
Publicado: (2015)

Open-Label Extension Study Comparing Latanoprost 0.005% Without vs With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension
por: Shen Lee, Bridgitte, et al.
Publicado: (2022)

Plague mitigation for prairie dog and black-footed ferret conservation: Degree and duration of flea control with 0.005% fipronil grain bait
por: Eads, David A., et al.
Publicado: (2023)

Effect of Erbium-yttrium, scandium, gallium and garnet (Er-YSGG) laser on the bond strength of lithium disilicate ceramics
por: Al Rifaiy, Mohammed Qasim
Publicado: (2018)

The pathway toward practical application of lithium-metal anodes for non-aqueous secondary batteries
por: Li, Panlong, et al.
Publicado: (2022)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
por: Inoue, Kenji, et al.
Publicado: (2014)

Antiperovskite Li(3)OCl Superionic Conductor Films for Solid‐State Li‐Ion Batteries
por: Lü, Xujie, et al.
Publicado: (2016)

Study of Bond Formation in Ceramic and Composite Materials Ultrasonically Soldered with Bi–Ag–Mg-Type Solder
por: Kolenak, Roman, et al.
Publicado: (2023)

Synergistic Effects of Salt Concentration and Working Temperature towards Dendrite-Free Lithium Deposition
por: Li, Panlong, et al.
Publicado: (2019)

A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
por: Godfrey, David A, et al.
Publicado: (2009)

Comparing the Efficacy of Latanoprost (0.005%), Bimatoprost (0.03%), Travoprost (0.004%), and Timolol (0.5%) in the Treatment of Primary Open Angle Glaucoma
por: Mishra, Deepak, et al.
Publicado: (2014)

Intraocular Pressure Reduction Effect of 0.005% Latanoprost Eye Drops in a Hyaluronic Acid-Chitosan Nanoparticle Drug Delivery System in Albino Rabbits
por: Rubenicia, Ana Marie L., et al.
Publicado: (2021)

Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma
por: Hagras, Sherein M, et al.
Publicado: (2021)

An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival
por: Freiberg, Josefine C., et al.
Publicado: (2022)

Standardizing critical current density measurements in lithium garnets
por: Klimpel, Matthias, et al.
Publicado: (2023)

Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan(®) and Arulatan(®)) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
por: Brant Fernandes, Rodrigo A, et al.
Publicado: (2019)

Study of Wettability and Solderability of SiC Ceramics with Ni by Use of Sn-Sb-Ti Solder by Heating with Electron Beam in Vacuum
por: Kolenak, Roman, et al.
Publicado: (2022)

Characterization of Sn–Sb–Ti Solder Alloy and the Study of Its Use for the Ultrasonic Soldering Process of SiC Ceramics with a Cu–SiC Metal–Ceramic Composite
por: Kolenak, Roman, et al.
Publicado: (2021)

Toward garnet electrolyte–based Li metal batteries: An ultrathin, highly effective, artificial solid-state electrolyte/metallic Li interface
por: Fu, Kun (Kelvin), et al.
Publicado: (2017)

Re-building Daniell Cell with a Li-ion exchange Film
por: Dong, Xiaoli, et al.
Publicado: (2014)

Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
por: Inoue, Kenji, et al.
Publicado: (2012)

Characterization of Zn-Mg-Sr Type Soldering Alloy and Study of Ultrasonic Soldering of SiC Ceramics and Cu-SiC Composite
por: Kolenak, Roman, et al.
Publicado: (2023)

Perspective on design and technical challenges of Li-garnet solid-state batteries
por: Kravchyk, Kostiantyn V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1b4i283ci6l1dq7nisieb16jla